tiprankstipranks
Trending News
More News >
Otsuka Corporation (JP:4768)
:4768

Otsuka (4768) AI Stock Analysis

Compare
1 Followers

Top Page

JP

Otsuka

(OTC:4768)

Rating:73Outperform
Price Target:
¥3,274.00
▲(11.51%Upside)
The company's strong financial performance is the most significant factor, supported by healthy revenue growth and a strong balance sheet. However, technical indicators are not particularly favorable, reflecting a neutral to slightly bearish sentiment. The fair valuation and attractive dividend yield provide some positive aspects.

Otsuka (4768) vs. iShares MSCI Japan ETF (EWJ)

Otsuka Business Overview & Revenue Model

Company DescriptionOtsuka Corporation provides system integration, support, and other services in Japan. The System Integration Business segment offers system services, including consulting, system design and development, transport and installation work, and network construction. It also provides management systems and collaborative software, such as ERP packages and groupware to cover a range of specialized fields, including CAD and web technologies; and software, hardware, intranet, and security products for the construction and expansion of computer networks. In addition, this segment sells computers, copiers, and communications equipment and software; and develops consigned software. The Service and Support Business segment offers supplies, hardware and software maintenance, telephone support, and outsourcing services; emergency computer rescue services for corporate and individual clients; and network support and services for the planning, design, construction, and operation of corporate information systems, as well as out-sources system engineers. It also provides educational support services. The company was founded in 1961 and is headquartered in Tokyo, Japan.
How the Company Makes MoneyOtsuka makes money through multiple revenue streams primarily derived from its pharmaceuticals and nutraceuticals divisions. In the pharmaceuticals sector, the company generates revenue by developing and selling prescription medications, with a strong emphasis on central nervous system disorders and oncology. Key products include antipsychotic medications and cancer treatments. The nutraceuticals division contributes to the company's earnings by offering health and wellness products, such as electrolyte drinks and nutritional supplements, directly to consumers. Otsuka also benefits from strategic partnerships and collaborations with other pharmaceutical companies and research institutions, expanding its market reach and leveraging shared resources for product development. The company invests significantly in research and development to maintain a robust pipeline of new products, ensuring long-term revenue growth.

Otsuka Financial Statement Overview

Summary
Otsuka's financial health is strong with robust revenue growth and profitability. The balance sheet is well-managed with low leverage and high liquidity, although recent declines in operating cash flow suggest potential pressures on cash generation.
Income Statement
85
Very Positive
Otsuka has demonstrated strong revenue growth, with a significant increase in total revenue over the past year. The gross profit margin is healthy, indicating efficient cost management. Net profit margin and EBIT margin show solid profitability, reflecting effective operational management. However, the recent decrease in operating cash flow raises some concerns about future profitability sustainability.
Balance Sheet
88
Very Positive
The company maintains a strong balance sheet with a solid equity ratio, suggesting a stable financial position. The debt-to-equity ratio is low, which indicates prudent use of leverage. Return on equity is robust, driven by consistent net income growth. The high level of cash and short-term investments enhances liquidity and financial flexibility.
Cash Flow
78
Positive
Otsuka's cash flow performance is generally positive, with consistent free cash flow generation. However, the notable decline in operating cash flow in the most recent TTM period could indicate potential pressures on cash generation. The free cash flow to net income ratio remains healthy, but the operating cash flow to net income ratio has weakened, suggesting a need for monitoring operational cash management.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue1.16T1.11T977.37B861.02B851.89B836.32B
Gross Profit230.98B224.47B203.98B184.17B176.89B173.72B
EBITDA88.15B82.65B72.86B63.06B63.81B63.92B
Net Income56.29B53.48B47.45B40.02B39.93B39.31B
Balance Sheet
Total Assets685.99B673.90B561.80B523.02B486.25B471.29B
Cash, Cash Equivalents and Short-Term Investments199.54B228.14B228.69B202.29B204.70B178.07B
Total Debt6.00B6.86B7.30B7.51B7.99B8.02B
Total Liabilities325.29B298.66B214.85B200.29B184.48B191.26B
Stockholders Equity356.34B370.80B343.11B319.39B298.74B277.35B
Cash Flow
Free Cash Flow12.71B34.49B61.30B22.12B46.99B23.63B
Operating Cash Flow17.99B37.71B71.65B29.20B57.87B32.50B
Investing Cash Flow-14.16B-11.95B-21.47B-8.36B-9.16B-8.72B
Financing Cash Flow-30.66B-25.89B-23.84B-23.31B-21.96B-20.99B

Otsuka Technical Analysis

Technical Analysis Sentiment
Positive
Last Price2936.00
Price Trends
50DMA
2927.81
Positive
100DMA
3106.63
Negative
200DMA
3268.06
Negative
Market Momentum
MACD
-10.63
Negative
RSI
53.97
Neutral
STOCH
17.59
Positive
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4768, the sentiment is Positive. The current price of 2936 is above the 20-day moving average (MA) of 2903.46, above the 50-day MA of 2927.81, and below the 200-day MA of 3268.06, indicating a neutral trend. The MACD of -10.63 indicates Negative momentum. The RSI at 53.97 is Neutral, neither overbought nor oversold. The STOCH value of 17.59 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4768.

Otsuka Peers Comparison

Overall Rating
UnderperformOutperform
Sector (63)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
73
Outperform
$1.11T19.7816.17%3.06%15.49%18.42%
63
Neutral
$33.22B5.99-11.76%1.91%5.50%-19.96%
DE9V2
€885.78M7.9510.70%4.02%
80
Outperform
¥56.72B9.01
2.60%11.02%65.67%
80
Outperform
¥247.17B9.58
3.46%17.47%493.79%
76
Outperform
¥70.01B10.24
3.26%7.56%12.07%
76
Outperform
¥93.70B19.27
1.32%6.46%67.90%
* Technology Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
JP:4768
Otsuka
2,936.00
-57.77
-1.93%
DE:9V2
Kaga Electronics Co., Ltd.
15.80
0.34
2.20%
JP:3107
Daiwabo Holdings Co., Ltd.
2,599.00
-204.93
-7.31%
JP:6638
Mimaki Engineering Co., Ltd.
1,923.00
96.43
5.28%
JP:7513
Kojima Co., Ltd.
1,215.00
269.41
28.49%
JP:9824
Senshu Electric Co., Ltd.
4,290.00
-978.45
-18.57%

Otsuka Corporate Events

Otsuka Corporation Reports Strong Q1 2025 Financial Results
Apr 30, 2025

Otsuka Corporation reported strong financial results for the first quarter of 2025, with a notable increase in net sales and profits compared to the previous year. The company’s performance reflects its robust market positioning and strategic initiatives, which have positively impacted its financial health and stakeholder confidence.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Jun 28, 2025